Table 4. Coefficients and LOO cross-validation parameters of allometric models describing selected pharmacokinetic parameters of tylosin A in turkeys of four different body weights (pooled).
| Parameters | ClB | Vdss | T1/2el | |
|---|---|---|---|---|
| Allometric models for PK parameters | ||||
| Unit | l/h | l | h | |
| N | 38 | 38 | 38 | |
| Coefficient | 4.179 | 0.541 | 0.776 | |
| Exponent | 0.575 | 0.815 | 0.481 | |
| R2 | 0.775 | 0.687 | 0.551 | |
| F | 71.37 | 39.77 | 27.35 | |
| P | < 0.01 | < 0.01 | < 0.01 | |
| LOO cross-validation parameters | ||||
| R2 | 0.665 | 0.525 | 0.432 | |
| Q2 | 0.614 | 0.466 | 0.338 | |
| Q2 − R2 | 0.051 | 0.032 | 0.094 | |
| Q2asym | 0.646 | 0.499 | 0.338 | |
| Q2asym − Q2 | 0.032 | 0.032 | 0.062 | |
| SS | 2,218.71 | 312.58 | 60.33 | |
| PRESS | 856.40 | 166.79 | 39.93 | |
| Validation outcome | - | - | - | |
F and P determined by linear regression analysis of observed vs. predicted values. For validation outcome, “-” denotes that model does not meet all validation criteria.
LOO, leave-one-out; ClB, body clearance; Vdss, volume of distribution at steady state; T1/2el, elimination half-life; N, number of individual parameters used to develop the model; SS, sum of squares; PRESS, predicted residual error sum of squares; Q2asym, Q2 asymptotic.